U.S. Department of Health and Human Services, National Institutes of Health
National Center on Sleep Disorders Research
Key facts
- Open now
- 73 grants
- Opening soon
- 5 grants
- Type of help
- Project grant
- Typical award
- Grants: $45 to $2,585,120: $457,671. SBIR Phase I - $319,005; Phase II - up to $301,224; STTR Phase I - $128,047; Phase II � up to $654,527
- Deadlines
- Contact the headquarters or regional location, as appropriate for application deadlines
Open now
- Emerging Global Leader Award (K43 Independent Clinical Trial Required) · Due Dec 3, 2026 · 57 days left
- Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed) · Due Dec 3, 2026 · 57 days left
- NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed) · Due Dec 4, 2026 · 58 days left
- Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) · Due Jan 7, 2027 · 92 days left
- NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required) · Due Jan 7, 2027 · 92 days left
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required) · Due Jan 7, 2027 · 92 days left
- NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required) · Due Jan 7, 2027 · 92 days left
- NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional) · Due Jan 7, 2027 · 92 days left
- Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed) · Due Mar 10, 2027 · 154 days left
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) · Due Apr 5, 2027 · 180 days left
- NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional) · Due Apr 5, 2027 · 180 days left
- Short Courses on Innovative Methodologies and Approaches in the Behavioral and Social Sciences (R25 Clinical Trials Not Allowed) · Due Apr 9, 2027 · 184 days left
- NHLBI Emerging Investigator Award (EIA) (R35 Clinical Trial Optional) · Due Apr 28, 2027 · 203 days left
- NHLBI Outstanding Investigator Award (OIA) (R35 Clinical Trial Optional) · Due Apr 28, 2027 · 203 days left
- Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Required) · Due May 7, 2027 · 212 days left
- Midcareer Investigator Award in Patient-Oriented Research (Parent K24 Independent Clinical Trial Not Allowed) · Due May 7, 2027 · 212 days left
- NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Required) · Due May 7, 2027 · 212 days left
- Midcareer Investigator Award in Patient-Oriented Research (Parent K24 Independent Clinical Trial Required) · Due May 7, 2027 · 212 days left
- Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Not Allowed) · Due May 7, 2027 · 212 days left
- NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Not Allowed) · Due May 7, 2027 · 212 days left
- Mentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial Required) · Due May 7, 2027 · 212 days left
- Mentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial Not Allowed) · Due May 7, 2027 · 212 days left
- Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed) · Due May 7, 2027 · 212 days left
- Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Not Allowed) · Due May 8, 2027 · 213 days left
- Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Required) · Due May 8, 2027 · 213 days left
- NHLBI Career Transition Award for Intramural Postdoctoral Fellows and Research Trainees (K22 Independent Clinical Trial Not Allowed) · Due Jul 12, 2027 · 278 days left
- NHLBI Career Transition Award for Intramural Postdoctoral Fellows and Research Trainees (K22 Clinical Trial Required) · Due Jul 12, 2027 · 278 days left
- Change of Recipient Organization (Type 7 Parent Clinical Trial Optional) · Due Jul 12, 2027 · 278 days left
- Successor-in-Interest (Type 6 Parent Clinical Trial Optional) · Due Jul 17, 2027 · 283 days left
- Interventions to Reduce Sleep Health Disparities (R01 - Clinical Trials Optional) · Due Sep 7, 2027 · 335 days left
- NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed) · Due Sep 7, 2027 · 335 days left
- Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Required) · Due Oct 25, 2027 · 383 days left
- Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed) · Due Nov 18, 2027 · 407 days left
- Catalyze: Product Definition Medical Device Prototype Optimization (R33 - Clinical Trial Not Allowed) · Due Dec 23, 2027 · 442 days left
- Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed) · Due Dec 23, 2027 · 442 days left
- Catalyze Product Definition Medical Device prototype design/testing and disease target identification and assay development (R61/R33 - Clinical Trial Not Allowed) · Due Dec 23, 2027 · 442 days left
- Catalyze: Product Definition for Small Molecules, Biologics, and Combination Products - Preliminary Product/Lead Series Identification and Combination Product Prototype (R33 - Clinical Trial Not Allowed) · Due Dec 23, 2027 · 442 days left
- Catalyze: Product Definition for Small Molecules, Biologics and Combination Products - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed) · Due Dec 23, 2027 · 442 days left
- NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed) · Due Jan 7, 2028 · 457 days left
- Dissemination and Implementation Research in Health (R01 Clinical Trial Optional) · Due Jan 7, 2028 · 457 days left
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed) · Due Jan 7, 2028 · 457 days left
- NIH Research Project Grant (Parent R01 Clinical Trial Required) · Due Jan 7, 2028 · 457 days left
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required) · Due Jan 7, 2028 · 457 days left
- NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Required) · Due Jan 7, 2028 · 457 days left
- Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed) · Due Jan 7, 2028 · 457 days left
- NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Not Allowed) · Due Jan 7, 2028 · 457 days left
- NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed) · Due Jan 7, 2028 · 457 days left
- Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32) · Due May 4, 2028 · 575 days left
- Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (Parent F31) · Due May 7, 2028 · 578 days left
- Ruth L. Kirschstein National Research Service Award (NRSA) Individual Senior Fellowship (Parent F33) · Due May 7, 2028 · 578 days left
- Ruth L. Kirschstein National Research Service Award (NRSA) Short-Term Institutional Research Training Grant (Parent T35) · Due May 7, 2028 · 578 days left
- Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions with NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30) · Due May 7, 2028 · 578 days left
- Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions Without NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30) · Due May 7, 2028 · 578 days left
- Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32) · Due May 7, 2028 · 578 days left
- NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01 - Clinical Trial Not Allowed) · Due May 8, 2028 · 579 days left
- INCLUDE Project: Exploratory/Developmental Research Awards for Down syndrome (R21 Clinical Trial Not Allowed) · Due Jun 15, 2028 · 617 days left
- INCLUDE Project: Clinical Trials Phased Awards for Down syndrome Research (R61/R33 Clinical Trial Required) · Due Jun 15, 2028 · 617 days left
- INCLUDE Project: Transformative Research Awards for Down syndrome (R01 Clinical Trial Not Allowed) · Due Jun 15, 2028 · 617 days left
- Lasker Clinical Research Scholar's Program (Si2/R00 Clinical Trial Optional) · Due Jul 7, 2028 · 639 days left
- Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed) · Due Aug 25, 2028 · 688 days left
- Development of Candidate Medical Countermeasures (MCMs) and Technologies Against Radiological/Nuclear or Chemical Threats (U01 Clinical Trial Not Allowed) · Due Oct 9, 2028 · 733 days left
- Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24 Clinical Trial Required) · Due Nov 2, 2028 · 757 days left
- Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required) · Due Nov 2, 2028 · 757 days left
- Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required) · Due Nov 2, 2028 · 757 days left
- Limited Competition: Small Grant Program for NHLBI K01/K08/K23/K25 Recipients (R03 Clinical Trial Optional) · Due Nov 7, 2028 · 762 days left
- Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) · Due Nov 30, 2028 · 785 days left
- HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional) · Due Feb 20, 2029 · 867 days left
- NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award (Parent [R44] Clinical Trial Optional) · Due Apr 5, 2029 · 911 days left
- SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional) · Due Apr 5, 2029 · 911 days left
- NIH Research Education Program - Research Experiences (Parent R25 - Clinical Trial Not Allowed) · Due May 5, 2029 · 941 days left
- NIH Research Educational Program - Mentoring Activities & Networks (Parent R25/UE5 - Clinical Trial Not Allowed) · Due May 5, 2029 · 941 days left
- NIH Research Education Program - Courses, Curriculum & Methods (Parent R25 - Clinical Trial Not Allowed) · Due May 25, 2029 · 961 days left
- Implementation Science to Advance HIV Prevention, Treatment, and Care (R61/R33 Clinical Trial Optional) · Due Jun 20, 2029 · 987 days left
Opening soon
Announced, but you can't apply yet. Get ready now.
- Limited Competition: Stimulating Access to Research in Residency Transition Scholar (StARRTS) · The funder's estimated date (Oct 14, 2025) has passed. Check the official notice Estimate, not confirmed by the funder
- NIH Research Program Projects (Parent P01 Clinical Trial Optional) · The funder's estimated date (Sep 25, 2026) has passed. Check the official notice Estimate, not confirmed by the funder
- Small Business Transition Grant for New Entrepreneurs (Parent R43/R44 Clinical Trial Optional) · Opens Nov 5, 2026 · due about Jan 5, 2027 Estimate, not confirmed by the funder
- Small Business Transition Grant for New Entrepreneurs (Parent R41/R42 Clinical Trial Optional) · Opens Nov 5, 2026 · due about Jan 5, 2027 Estimate, not confirmed by the funder
- Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required) · Opens Nov 16, 2026 · due about Feb 16, 2027 Estimate, not confirmed by the funder
What it pays for
The National Heart, Lung, and Blood Institute (NHLBI) provides global leadership for a research, training, and education program to promote the prevention and treatment of heart, lung, and blood diseases and enhance the health of all individuals so that they can live longer and more fulfilling lives. The National Center on Sleep Disorders Research (NCSDR) supports research and research training related to sleep disordered breathing, and the fundamental functions of sleep and circadian rhythms. The center also stewards several forums that facilitate the coordination of sleep research across NIH, other federal agencies and outside organizations, including the Sleep Disorders Research Advisory Board and an NIH-wide Sleep Research Coordinating Committee. The center also participates in the translation of new sleep research findings for dissemination to health care professionals and the public. Small Business Innovation Research (SBIR) program: To stimulate technological innovation; use small business to meet Federal research and development needs; foster and encourage participation in innovation and entrepreneurship by socially and economically disadvantaged persons; and increase private-sector commercialization of innovations derived from Federal research and development funding. Small Business Technology Transfer (STTR) program: To stimulate technological innovation; foster technology transfer through cooperative R&D between small businesses and research institutions, and increase private sector commercialization of innovations derived from federal R&D.
Who can apply
Any nonprofit organization engaged in biomedical research and institutions or companies organized for profit may apply for almost any kind of grant. Only domestic, non-profit, private or public institutions may apply for NRSA Institutional Research Training Grants. An individual may apply for an NRSA or, in some cases, for a research grant if adequate facilities to perform the research are available. SBIR grants can be awarded only to United States small business concerns (entities that are independently owned and operated for profit, or owned by another small business that itself is independently owned and operated for profit or owned by multiple venture capital operating companies, hedge funds, private equity firms, or any combination of these, and have no more than 500 employees including affiliates). Primary employment (more than one-half time) of the principal investigator must be with the small business at the time of award and during the conduct of the proposed project. In both Phase I and Phase II, the research must be performed in the U.S. or its possessions except under rare and unique circumstances where foreign components are thoroughly justified and necessary to the overall completion of the project. To be eligible for funding, a grant application must be approved for scientific merit and program relevance by a scientific review group and a national advisory...
How applications are judged
The major elements in evaluating proposals include assessments of: (1) The scientific merit and general significance of the proposed study and its objectives; (2) the technical adequacy of the experimental design and approach; (3) the competency of the proposed investigator or group to successfully pursue the project; (4) the adequacy of the available and proposed facilities and resources; (5) the necessity of the budget components requested in relation to the proposed project; and (6) the relevance and importance to announced program objectives. The following criteria will be used in considering the scientific and technical merit of SBIR/STTR Phase I grant applications: (1) The soundness and technical merit of the proposed approach; (2) the importance of the problem the proposed research will address; (3) the qualifications of the proposed principal investigator, supporting staff, and consultants; (4) the technological innovation of the proposed research; (5) the potential of the proposed research for commercial application; (6) the appropriateness of the budget requested; (7) the adequacy and suitability of the facilities and research environment; (8) the adequacy of plans to include both genders and minorities and their subgroups as appropriate for the scientific goals of the research. Plans for the recruitment and retention of subjects will be evaluated; and (9) where applicable, the adequacy of assurances detailing the proposed means for (a) safeguarding human or...
Match
None required (federal program listing).